BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38053743)

  • 1. Testicular involvement in mantle cell lymphoma: An analysis of 16 patients.
    Alkhalili S; Manogna D; Safah H; Ellent E; Beversdorf W; Arora R; Saba NS
    Leuk Res Rep; 2023; 20():100397. PubMed ID: 38053743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiparameter immunohistochemical analysis of the cell cycle proteins cyclin D1, Ki-67, p21WAF1, p27KIP1, and p53 in mantle cell lymphoma.
    Izban KF; Alkan S; Singleton TP; Hsi ED
    Arch Pathol Lab Med; 2000 Oct; 124(10):1457-62. PubMed ID: 11035575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD10-positive mantle cell lymphoma: clinicopathologic and prognostic study of 30 cases.
    Xu J; Medeiros LJ; Saksena A; Wang M; Zhou J; Li J; Yin CC; Tang G; Wang L; Lin P; Li S
    Oncotarget; 2018 Feb; 9(14):11441-11450. PubMed ID: 29545910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD5-negative blastoid variant mantle cell lymphoma: a diagnostic dilemma.
    Yamamoto N; Maeshima AM; Taniguchi H; Makita S; Fukuhara S; Munakata W; Suzuki T; Maruyama D; Izutsu K
    Hum Pathol; 2021 May; 111():84-91. PubMed ID: 33727166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclin D1-negative blastoid mantle cell lymphoma identified by SOX11 expression.
    Zeng W; Fu K; Quintanilla-Fend L; Lim M; Ondrejka S; Hsi ED
    Am J Surg Pathol; 2012 Feb; 36(2):214-9. PubMed ID: 22251940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mantle cell lymphoma: 2013 Update on diagnosis, risk-stratification, and clinical management.
    Vose JM
    Am J Hematol; 2013 Dec; 88(12):1082-8. PubMed ID: 24273091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aggressive Cyclin D1 Negative Blastoid Variant Mantle Cell Lymphoma-A Case Report.
    Loungani L; Mundhe R; Chinoy R
    Int J Surg Pathol; 2022 Apr; 30(2):190-194. PubMed ID: 34180720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blastoid Mantle Cell Lymphoma of the Palate: Report of a Rare Aggressive Entity and Review of the Literature.
    Georgaki M; Theofilou VI; Pettas E; Piperi E; Stoufi E; Panayiotidis P; Nikitakis NG
    Head Neck Pathol; 2022 Jun; 16(2):631-642. PubMed ID: 34716903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blastoid Mantle Cell Lymphoma.
    Jain P; Wang M
    Hematol Oncol Clin North Am; 2020 Oct; 34(5):941-956. PubMed ID: 32861288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Large cell variants of CD5+, CD23- B-cell lymphoma/leukemia.
    Dunphy CH; Perkins SL
    Arch Pathol Lab Med; 2001 Apr; 125(4):513-8. PubMed ID: 11260626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mantle cell lymphoma: 2015 update on diagnosis, risk-stratification, and clinical management.
    Vose JM
    Am J Hematol; 2015 Aug; 90(8):739-45. PubMed ID: 26103436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cyclin D1-negative mantle cell lymphoma with an IGL-CCND2 translocation that relapsed with blastoid morphology and aggressive clinical behavior.
    Kurita D; Takeuchi K; Kobayashi S; Hojo A; Uchino Y; Sakagami M; Ohtake S; Takahashi H; Miura K; Iriyama N; Sugitani M; Miyoshi H; Hatta Y; Ohshima K; Takei M
    Virchows Arch; 2016 Oct; 469(4):471-6. PubMed ID: 27457074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mantle cell lymphoma: 2012 update on diagnosis, risk-stratification, and clinical management.
    Vose JM
    Am J Hematol; 2012 Jun; 87(6):604-9. PubMed ID: 22615102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytogenetic findings in blastoid mantle cell lymphoma.
    Khoury JD; Sen F; Abruzzo LV; Hayes K; Glassman A; Medeiros LJ
    Hum Pathol; 2003 Oct; 34(10):1022-9. PubMed ID: 14608536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinicopathologic features and prognosis of mantle cell lymphoma: an analysis of 349 cases].
    Hou WH; Wei P; Xie JL; Zheng YY; Zhang YL; Zhou XG
    Zhonghua Bing Li Xue Za Zhi; 2018 Jun; 47(6):417-422. PubMed ID: 29886584
    [No Abstract]   [Full Text] [Related]  

  • 16. Cooccurrence of CD10-Positive and CD10-Negative Mantle Cell Lymphoma Complicated With Central Nervous System Involvement Solely by CD10-Positive Population.
    Fukushima N; Mino T; Arihiro K; Ichinohe T
    Cureus; 2022 Jan; 14(1):e21341. PubMed ID: 35186599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skin Involvement of Mantle Cell Lymphoma May Mimic Primary Cutaneous Diffuse Large B-cell Lymphoma, Leg Type.
    Wehkamp U; Pott C; Unterhalt M; Koch K; Weichenthal M; Klapper W; Oschlies I
    Am J Surg Pathol; 2015 Aug; 39(8):1093-101. PubMed ID: 26034867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mantle cell lymphoma: 2017 update on diagnosis, risk-stratification, and clinical management.
    Vose JM
    Am J Hematol; 2017 Aug; 92(8):806-813. PubMed ID: 28699667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SOX11-negative Mantle Cell Lymphoma: Clinicopathologic and Prognostic Features of 75 Patients.
    Xu J; Wang L; Li J; Saksena A; Wang SA; Shen J; Hu Z; Lin P; Tang G; Yin CC; Wang M; Medeiros LJ; Li S
    Am J Surg Pathol; 2019 May; 43(5):710-716. PubMed ID: 30768440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ki-67 Labeling Indices in 'Classic' versus 'Blastoid' Mantle Cell Lymphomas--Proposed Cutoff Values for Routine Diagnostic Workup.
    Pervez S; Haroon S; Awan D
    Asian Pac J Cancer Prev; 2015; 16(15):6591-4. PubMed ID: 26434879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.